The PI3K-AKT-mTOR pathway serves as the metabolic-proliferative hub in ovarian cancer, driving tumorigenesis by orchestrating cell survival, cell cycle progression, and DNA repair. This evidence concerns the gene AKT1 and ovarian cancer.